Vaccination mitigates risk of COVID-19-related hospitalization in patients with celiac disease

Healio (3/9, Burba) reports, “Vaccination against COVID-19 is strongly recommended in patients with celiac disease, who are at greater risk for hospitalization due to SARS-CoV-2 infection compared with people who do not have celiac disease, according to research” published in Clinical Gastroenterology and Hepatology. According to the findings, “24% of patients were hospitalized in the CD group because of COVID-19 compared with 11% of patients in the reference group…and vaccination was associated with a ‘significantly decreased risk’ for hospitalization.” The researchers said, “there were no significant differences between CD and non-CD patients with respect to ICU requirement, mortality or thrombosis.”